29 apr: Royal Copenhagen lancerer Sitecore baseret website til optimering..
02 maj: Ranch i Texas: Bo som Bush
29-04-2008 14:03:00

Panorama Capital Closes Its Inaugural Fund

Panorama Capital LLC today announced it has closed Panorama Capital

L.P., a $240 million venture capital fund targeting life-sciences and

technology companies. After a long history of successful investing over

numerous fund cycles, this fund marks the first for the Panorama team as

an independent brand. The premiere fund will be invested in four major

areas: Life Sciences, Internet, Semiconductors, and Internet

Infrastructure & Services. Panorama, which has already made six new

investments from the fund, has total funds under management in excess of

$700 million.

Times of economic volatility have always

produced for us game-changing companies that make this a great time to

be in the venture capital business with a new fund,

said Chris Albinson, managing director of Panorama Capital. Coupled

with our love of disruptive market opportunities for creating value, our

market insight, and our experience partnering with entrepreneurs to

build exceptional companies, we at Panorama Capital foresee a lucrative

future for investing.

Since 1990, the Panorama team has consistently produced top-quartile

returns, including successful exits from over 50 IPOs and M&A

transactions. Recent exits include: Corus Pharma, Piramed Limited,

Portal Player, Renovo Limited, Seattle Genetics, Sierra Logic, Tacit

Networks, Valere Power, and Yipes Holdings.

Panoramas investment professionals have

extensive experience investing with entrepreneurs in companies at all

stages of development. Four advisory boards augment the teams

investment network and are comprised of 80 members from industry-leading

companies including AT&T, Agilent, Cisco, Facebook, Genentech, GigaOm,

Google, Johnson & Johnson, Microsoft, Priceline, Rambus, Red Hat, Roche,

Schering-Plough, TechCrunch, Texas Instruments, and Yahoo.

Panorama Capital works attentively with us

day after day supporting our vision for an innovative media enterprise,

said John Battelle, CEO of Federated Media. From

finding key members of the team, helping to shape the model and

technology, and even acting as our corporate development team in key

situations, my experience working with Panorama has been nothing short

of excellent.

As our name suggests, we seek expansive

opportunities across the investment horizon,

said Rod Ferguson, managing director of Panorama Capital. Using

our team-oriented approach, deep domain expertise and extensive business

ecosystem as a roadmap to successful investing allows us to be effective

investors throughout the life sciences and technology sectors.

About Panorama Capital

Panorama Capital (http://www.panoramacapital.com)

is a venture capital firm focused on life sciences and technology

companies. Panorama Capital was founded in 2005 by: Srinivas Akkaraju

M.D., Ph.D.; Christopher J. Albinson; Rodney A. Ferguson, J.D., Ph.D.;

Shahan D. Soghikian; and Damion E. Wicker, M.D., along with a core team

of investment professionals who worked together for many years.

Together, this team has a singular focus: helping entrepreneurs build

market-leading companies. Panorama invests in entrepreneurs and teams

who share its values: a passion to build great companies; an unyielding

focus on people and teamwork; and a commitment to integrity. Panoramas

philosophy is to make that same commitment to the teams it supports,

over and above its financial investment, and to take a hands-on, highly

collaborative approach to investing, bringing to each portfolio company

the team´s extensive operating and investing experience.

Antenna Group (for Panorama Capital)

Jasmine Harris, 415-977-1929

jasmine@antennagroup.com

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
20 dec
 
Det er meget velbeskrevet i talrige bøger og artikler, at tilstandene i store dele af verden udenfor..
49
18 dec
VWS
Normal 0 21 false false false DA X-NONE X-NONE ..
30
18 dec
GEN
Med FDA´s godkendelse af Amgens (Micromet) godkendelse af Blincyto (blinatumomab), fik vi for alvor ..
27
18 dec
PNDORA
Nu har jeg købt og solgt aktier i 8 år og var os her på debatten for 4-5 år siden men har glemt mit ..
24
23 dec
 
Kryler, den første sætning var helt unødvendig. Prøv at højne niveauet istedet for at fremhæve hvor ..
17
18 dec
 
  Jeg er gratist, jeg læser med på EI uden at skrive. Det er sjældent, man kan få gratis lunch; men ..
13
21 dec
MY
Det er jo en ejendommelig debat, der er kommet ud af det spørgsmål. Der er jo ingen, der nogensinde ..
12
20 dec
VWS
Det er nemt at lave en hurtig statistik over perioden fra medio December til medio Januar, på basis ..
11
20 dec
VWS
Kære Mena: Her definationen af et JV: http://da.wikipedia.org/wiki/Joint_venture   "Parterne er også..
10
20 dec
VWS
Mena: du har altså ikke ret i det er 2 "vidt forskellige" selskaber. Vestas Wind Systems A/S er mode..
9

Prisen på jernmalm falder til laveste niveau siden 2009

23-12-2014 16:41:03
Prisen på jernmalm fortsætter med at falde i tirsdagens handel, hvor et prisdyk på 1,6 pct. til 66,84 dollar per ton har bragt prisen på jernmalm ned i laveste ..

Shipping: Baltic Dry-indekset falder for 24. dag i træk

23-12-2014 14:12:02
Tørlastindekset Baltic Dry falder tirsdag med 0,8 pct. til 788 point. Det fremgår af data fra Bloomberg News.Det er dermed 24. fald i streg for indekset. Det er..

Aktier/åbning: Cementordre løfter FLSmidth

23-12-2014 09:16:51
Det danske aktiemarked har fået en let positiv start på tirsdagens handel og styrer dermed mod femte stigning i træk. Øverst i C20 ligger FLSmidth, der har vund..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
25. december 2014 08:14:19
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20141219.2 - EUROWEB1 - 2014-12-25 08:14:19 - 2014-12-25 08:14:19 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x